In the last trading session, 1.0 million shares of the Twist Bioscience Corp (NASDAQ:TWST) were traded, and its beta was 2.38. Most recently the company’s share price was $36.98, and it changed around $1.39 or 3.91% from the last close, which brings the market valuation of the company to $2.22B. TWST currently trades at a discount to its 52-week high of $60.90, offering almost -64.68% off that amount. The share price’s 52-week low was $27.12, which indicates that the current value has risen by an impressive 26.66% since then. We note from Twist Bioscience Corp’s average daily trading volume that its 10-day average is 0.97 million shares, with the 3-month average coming to 1.17 million.
Twist Bioscience Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.73. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 2 recommended TWST as a Hold, whereas 7 deemed it a Buy, and 1 rated it as Underweight.
Twist Bioscience Corp (NASDAQ:TWST) trade information
Instantly TWST has showed a green trend with a performance of 3.91% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 38.86 on recent trading dayincreased the stock’s daily price by 4.84%. The company’s shares are currently down -22.96% year-to-date, but still up 0.52% over the last five days. On the other hand, Twist Bioscience Corp (NASDAQ:TWST) is 21.93% up in the 30-day period. We can see from the shorts that 10.31 million shares have been sold at a short interest cover period of 8.51 day(s).
The consensus price target as assigned by Wall Street analysts is $50, which translates to bulls needing to increase their stock price by 26.04% from its current value. Analyst projections state that TWST is forecast to be at a low of $44 and a high of $58.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 1.70%. Twist Bioscience Corp earnings are expected to increase by 40.64% in 2025, but the outlook is positive 37.99% per year for the next five years.
TWST Dividends
Twist Bioscience Corp’s next quarterly earnings report is expected to be released on 2025-May-05.
Twist Bioscience Corp (NASDAQ:TWST)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.98% of Twist Bioscience Corp shares, and 114.80% of them are in the hands of institutional investors. The stock currently has a share float of 117.12%. Twist Bioscience Corp stock is held by 375.0 institutions, with ARK INVESTMENT MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 10.5415% of the shares, which is about 6.13 million shares worth $302.06 million.
ARTISAN PARTNERS LIMITED PARTNERSHIP, with 10.4371% or 6.07 million shares worth $299.06 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK ETF Trust-ARK Innovation ETF and ARK ETF Trust-ARK Genomic Revolution ETF were the top two Mutual Funds as of May 31, 2025 . The former held 3.65 shares worth $135.06 million, making up 6.10% of all outstanding shares. On the other hand, ARK ETF Trust-ARK Genomic Revolution ETF held roughly 2.06 shares worth around $76.06 million, which represents about 3.43% of the total shares outstanding.
